PlainRecalls
FDA Drug Moderate Class II Terminated

Phenylephrine HCL PF INJ in 0.9% Sodium Chloride, 1000mcg/10mL (100mgc/mL), *Contains Sulfites*, 10mL Single-Dose Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-236-16, barcode 8 69623 23616 2.

Reported: July 3, 2019 Initiated: June 18, 2019 #D-1424-2019

Product Description

Phenylephrine HCL PF INJ in 0.9% Sodium Chloride, 1000mcg/10mL (100mgc/mL), *Contains Sulfites*, 10mL Single-Dose Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-236-16, barcode 8 69623 23616 2.

Reason for Recall

Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Details

Recalling Firm
Premier Pharmacy Labs Inc
Units Affected
1040 syringes
Distribution
Nationwide in the USA
Location
Weeki Wachee, FL

Frequently Asked Questions

What product was recalled?
Phenylephrine HCL PF INJ in 0.9% Sodium Chloride, 1000mcg/10mL (100mgc/mL), *Contains Sulfites*, 10mL Single-Dose Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-236-16, barcode 8 69623 23616 2.. Recalled by Premier Pharmacy Labs Inc. Units affected: 1040 syringes.
Why was this product recalled?
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 3, 2019. Severity: Moderate. Recall number: D-1424-2019.